8 April 2019
By achieving certification to the International Organization for Standardization ISO 9001:2015 standard, REPROCELL USA Inc. has demonstrated its ability to consistently provide various services and products that consistently meet customer requirements. In addition, REPROCELL USA Inc. aims to enhance customer satisfaction through the effective implementation of its quality management system, including the continuous improvement of the system and its processes with the focus on providing assurance for conformity to customer requirements and expectations.
“It is our commitment that REPROCELL constantly meets and exceeds the customer expectations through our services, products and technology, and the accreditation clearly demonstrates our ability to do so.” said Rama Modali, CEO of REPROCELL USA Inc. “For the past 30 years, the organization has delivered superior services extracting nucleic acids, genotyping and expression analysis. We also offer human tissues, both fresh frozen and FFPE samples, serum, plasma, whole blood and prospective collections. In addition to offering various stem cell related products, we have added various services to our portfolio such as stem cell and preclinical drug discovery assay services. Our customers, whether bio-pharmaceutical companies or public research institutions, have come to expect the highest quality control with reduced project cycle time, along with the ability to overcome challenging business and scientific hurdles. With the ISO accreditation, our customers can be confident of our continued commitment to providing the highest quality services, products and technology.”
ISO 9001 is the world’s most popular quality management system framework. More than a million organizations in over 175 countries are certified to its requirements. The standard’s focus is on the use of planning to drive success through improved customer satisfaction, motivation of personnel and continual improvement.